Pfizer's Xeljanz shows efficacy against COVID-19 pneumonia
- BySeeking Alpha-
Pfizer's JAK inhibitor Xeljanz lowers the death and respiratory failures rates in COVID-19 patients with pneumonia compared to placebo.
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Inc (PFE)
Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| NSE | INR | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| NSE | INR | Real-time | ||
| BSE | INR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| Moscow | RUB | Real-time | ||
| KASE | KZT | Delayed | ||
| Lima | USD | Delayed |
39.48
+0.18(+0.46%)
After Hours
39.50
+0.02(+0.05%)
- Real-time Data
- Volume:19,577,872
- Bid/Ask:39.45/39.50
- Day's Range:39.07 - 39.59
PFE Overview
- Prev. Close
- 39.3
- Day's Range
- 39.07-39.59
- Revenue
- 46.41B
- Open
- 39.27
- 52 wk Range
- 29.96-43.08
- EPS
- 1.67
- Volume
- 19,577,872
- Market Cap
- 221B
- Dividend (Yield)
- 1.56(3.97%)
- Average Volume (3m)
- 27,388,695
- P/E Ratio
- 23.55
- Beta
- 0.73
- 1-Year Change
- 24.13%
- Shares Outstanding
- 5,597,693,867
- Next Earnings Date
- Aug. 03, 2021
What is your sentiment on Pfizer Inc?
or
Market is currently closed. Voting is open during market hours.
Pfizer Inc News
- Pfizer's Xeljanz Cuts Incidence Of Death, Respiratory Failure In COVID-19 Patients, Brazilian Study Shows
- ByBenzinga-
Pfizer Inc (NYSE: PFE) said that its oral rheumatoid arthritis drug Xeljanz (tofacitinib) reduced death or respiratory failure in hospitalized COVID-19 patients with pneumonia in...
- AstraZeneca Weaker After Australia Limits Covid Shot to People Over 60
- ByInvesting.com-
By Dhirendra TripathiInvesting.com -- AstraZeneca (NASDAQ:AZN) shares were down by more than 1% in Thursday’s premarket trading following Australia’s decision to limit the...
Pfizer Inc Analysis
- Pfizer, Moderna Jabs Cause Heart Inflammation In Some Young Men, CDC Finds
- ByZeroHdge-
Pfizer, Moderna Jabs Cause Heart Inflammation In Some Young Men, CDC FindsAs American public health officials and political leaders struggle to entice more young adults to accept...
- Science Sides with Pfizer, Despite Vaccine Fears
- ByTipRanks-
Notwithstanding the horrors of the novel coronavirus pandemic, one definitive bright spot that emerged is the rapid-fire development of COVID-19 vaccines. In particular, Pfizer...
- Pfizer: mRNA COVID Vaccine Is Transforming And More To Come
- BySeeking Alpha-
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Neutral | Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Sell | Neutral | Strong Buy |
| Summary | Strong Buy | Strong Buy | Neutral | Neutral | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 56.14 | 56.70 | 55.22 | +0.92 | +1.67% | 656.73K | Toronto | |||
| 3.57 | 3.59 | 3.57 | -0.010 | -0.28% | 724.15K | Toronto | |||
| 12.12 | 12.40 | 11.80 | -0.26 | -2.10% | 2.05M | Toronto | |||
| 0.155 | 0.00 | 0.00 | 0.0000 | 0.00% | 517.56K | CSE | |||
| 18.49 | 18.65 | 18.35 | -0.11 | -0.59% | 63.83K | Toronto | |||
| 0.29 | 0.00 | 0.00 | -0.010 | -3.33% | 248.93K | NEO | |||
| 40.97 | 41.07 | 40.82 | +0.03 | +0.07% | 35.99K | Toronto | |||
| 35.64 | 35.83 | 35.41 | -0.02 | -0.06% | 271.89K | Toronto | |||
| 11.67 | 12.03 | 11.485 | -0.470 | -3.87% | 2.66M | Toronto | |||
| 6.16 | 6.39 | 6.07 | -0.24 | -3.75% | 4.02M | Toronto | |||
| 0.175 | 0.00 | 0.00 | -0.0700 | -28.57% | 105.50K | TSXV | |||
| 84.14 | 87.09 | 83.65 | -2.32 | -2.68% | 805.83K | Toronto | |||
| 41.00 | 41.15 | 40.93 | -0.01 | -0.02% | 6.07K | Toronto | |||
| 54.76 | 57.29 | 54.03 | -2.50 | -4.37% | 299.78K | Toronto | |||
| 7.97 | 8.03 | 7.65 | +0.320 | +4.18% | 951.06K | Toronto |
Pfizer Inc Company Profile
Pfizer Inc Company Profile
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Read More
- 2021-06-16 07:20:33
They are all thieves - 2021-05-14 21:34:49
very undervalued stock - 2021-05-10 15:09:24slow and steady
- 2021-05-03 19:42:29
better off with Biontech, no big gains here! - 2021-04-07 23:05:27It’s right time to buy, before go up
- 2021-03-18 13:00:20Pfizer needs to take a vaccine so they grow
- 2021-03-17 11:18:28now what? does it look like a reversal
- 2021-03-11 14:46:41
Everyone had Pfizer for their vaccin option and ofcourse it didn’t even move lol - 2021-03-10 17:54:18Wait until May!
- 2021-02-24 19:00:31
lol this is hilariousShow previous replies (2)- 2021-02-25 13:04:23why is it still going down!!!!!!
- 2021-03-01 17:38:11This is one of the weirdest stock of all time!
- 2021-03-12 04:16:28I'm stuck since December, I couldn't sell my stocks, I'm still waiting for a reversal
- 2021-02-23 19:23:07
when is the quarter statement getting released?? - 2021-02-10 15:02:46Wtf
- 2021-02-10 15:02:15Wtf
- 2021-02-09 02:11:45Moderna $186
- 2021-02-08 18:26:03are they giving vaccine free?
- 2021-02-05 03:09:33🤣🤣🤣
- 2021-02-05 02:13:05I hope whoever is making it go down would get covid and the vaccine would not work on them and theyd have a fever above 40°
- 2021-02-05 02:12:05I hope whoever is making this stock fall would get diarrhea and stay in the bathroom for 6 months
- 2021-02-04 17:23:00this stock doesn't take off yet 😠
- 2021-02-03 16:15:56
Investors trap - 2021-02-02 08:30:29Junk
- 2021-02-02 17:44:10nah it should touch 50$ this year
- 2021-01-30 03:43:03
Oh my god its not contoled by wall stereet or hedge fund? - 2021-01-29 22:14:11This is a crap stock
- 2021-01-30 03:39:29Agreed
- 2021-01-28 13:22:44Why is Pfizer not moving up😭 i thought this will rock the market😭
- 2021-01-21 01:35:20Whait did Pfizer penefits the vaccine =zero 00000000
- 2021-01-29 18:00:45pretty much
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.